USD 73.49
(2.36%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 520.4 Million USD | 8557.53% |
2022 | 6.01 Million USD | 18.96% |
2021 | 5.05 Million USD | 5.25% |
2020 | 4.8 Million USD | 93.51% |
2019 | 2.48 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | -100.0% |
2010 | 5.25 Million USD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q3 | 534.55 Million USD | 0.66% |
2024 Q2 | 531.02 Million USD | 0.9% |
2024 Q1 | 526.29 Million USD | 1.13% |
2023 Q3 | 523.03 Million USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 FY | 520.4 Million USD | 8557.53% |
2023 Q1 | - USD | -100.0% |
2023 Q4 | 520.4 Million USD | -0.5% |
2022 Q3 | - USD | 0.0% |
2022 Q4 | 6.01 Million USD | 0.0% |
2022 FY | 6.01 Million USD | 18.96% |
2022 Q1 | - USD | -100.0% |
2022 Q2 | - USD | 0.0% |
2021 Q3 | 5.42 Million USD | -8.79% |
2021 Q4 | 5.05 Million USD | -6.86% |
2021 Q2 | 5.94 Million USD | 10.7% |
2021 FY | 5.05 Million USD | 5.25% |
2021 Q1 | 5.37 Million USD | 83.0% |
2020 Q1 | 1.77 Million USD | 55.43% |
2020 Q2 | 2.32 Million USD | 30.93% |
2020 Q3 | 2.61 Million USD | 12.31% |
2020 Q4 | 2.93 Million USD | 12.49% |
2020 FY | 4.8 Million USD | 93.51% |
2019 Q2 | 740 Thousand USD | -7.85% |
2019 Q1 | 803 Thousand USD | 0.0% |
2019 Q3 | 871 Thousand USD | 17.7% |
2019 FY | 2.48 Million USD | 0.0% |
2019 Q4 | 1.14 Million USD | 31.11% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2013 Q2 | - USD | 0.0% |
2013 Q3 | - USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 Q2 | - USD | 0.0% |
2012 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2012 Q3 | - USD | 0.0% |
2011 FY | - USD | -100.0% |
2011 Q4 | - USD | 0.0% |
2010 FY | 5.25 Million USD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Abbott Laboratories | 15.87 Billion USD | 96.721% |
Allurion Technologies Inc. | 41.85 Million USD | -1143.29% |
Artivion, Inc. | 359.34 Million USD | -44.822% |
Avanos Medical, Inc. | 209.1 Million USD | -148.878% |
Butterfly Network, Inc. | 25.02 Million USD | -1979.37% |
Butterfly Network, Inc. | 25.02 Million USD | -1979.37% |
Bio-Rad Laboratories, Inc. | 1.4 Billion USD | 62.984% |
Boston Scientific Corporation | 9.49 Billion USD | 94.517% |
CONMED Corporation | 991.25 Million USD | 47.5% |
Edwards Lifesciences Corporation | 694.9 Million USD | 25.111% |
Paragon 28, Inc. | 112.03 Million USD | -364.522% |
Glaukos Corporation | 383.73 Million USD | -35.614% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -1994.518% |
Integer Holdings Corporation | 1.04 Billion USD | 50.007% |
Medtronic plc | 26.04 Billion USD | 98.002% |
Myomo, Inc. | 601.3 Thousand USD | -86446.051% |
Nevro Corp. | 221.82 Million USD | -134.599% |
Owlet, Inc. | 15.21 Million USD | -3320.11% |
Penumbra, Inc. | 234.34 Million USD | -122.069% |
Vicarious Surgical Inc. | 14.83 Million USD | -3408.657% |
Smith & Nephew plc | 3.08 Billion USD | 83.126% |
Sonendo, Inc. | 40.35 Million USD | -1189.693% |
STERIS plc | 3.38 Billion USD | 84.618% |
Stryker Corporation | 12.99 Billion USD | 95.995% |
Vapotherm, Inc. | 112.39 Million USD | -363.026% |
Zimmer Biomet Holdings, Inc. | 5.99 Billion USD | 91.32% |